Lanosterol synthase deficiency promotes tumor progression by orchestrating PDL1‐dependent tumor immunosuppressive microenvironment
Yuan Gao(Army Medical University), Hongming Miao(Army Medical University), Dapeng Zhang(Liaocheng University), Kun Zhao(Army Medical University), Yulan Huang(Army Medical University), Meng Wang(Tongji University), Weidong Xiao(Army Medical University), Feng Yang(Army Medical University), Rongchen Shi(Army Medical University), Na Luo(Army Medical University), Xiaoqing Peng(Chongqing University)
Cited by 9
Related Papers
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
|Signal Transduction and Targeted Therapy|2020|1.6k
LncRNA HCP5 promotes follicular thyroid carcinoma progression via miRNAs sponge
|Cell Death and Disease|2018|160
Genetically programmable cell membrane-camouflaged nanoparticles for targeted combination therapy of colorectal cancer
|Signal Transduction and Targeted Therapy|2024|81
FOXO1 Increases CCL20 to Promote NF-κB-Dependent Lymphocyte Chemotaxis
|Molecular Endocrinology|2012|44